Customers are to be offered discounted weight loss treatments through insurance giant Vitality in a UK first.

The group, which is UK’s third-largest health insurer behind Bupa and Axa, is to offer discounts of up to 20 per cent for medications such as Wegovy and Mounjaro to its 1.9 million members.

The offer is to be based on their body mass index (BMI) and weight-related health conditions, Vitality said.

Policy holders can apply for the new medication pathway if they have a BMI of 35 or more.

The service includes coaching with a dietitian and discounted anti-obesity medications for up to a year based on their health risks.

The news comes ahead of Vitality’s CEO, Neville Koopowitz, appearing on the latest episode of City AM’s interview series, Boardroom Uncovered.

The CEO opens up about the challenges the insurance industry has faced in recent years as well as why premiums are not expected to go down following a post-Covid spike.

He also talks about how Vitality’s push to make its members healthier alleviates pressure on the NHS.

‘Weight loss can transform lives’

Dr Katie Tryon, chief commercial director, VitalityHealth, said: “Over the past year, the potential of weight-management medications has become more evident and while they are not a universal solution, they can be a useful tool in improving health.